Location History:
- Gyeonggi-do, KR (2007 - 2008)
- Suwon, KR (2010 - 2011)
Company Filing History:
Years Active: 2007-2011
Title: Myung Suk Oh: Innovator in Interferon Beta Purification
Introduction
Myung Suk Oh is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the purification of interferon beta. With a total of four patents to his name, his work has implications for therapeutic applications in medicine.
Latest Patents
Myung Suk Oh's latest patents focus on processes for purifying human interferon beta from recombinant cultures. One patent describes a method that involves affinity chromatography and cation exchange chromatography. This process includes adsorbing the interferon beta-containing culture to an equilibrated affinity chromatography column, followed by a series of washing steps with specific buffer solutions. Another patent outlines a similar purification process using affinity chromatography and reversed-phase high-performance liquid chromatography (RP-HPLC). Both methods emphasize the importance of maintaining specific pH levels and concentrations of propylene glycol and sodium chloride during the purification process.
Career Highlights
Throughout his career, Myung Suk Oh has worked with prominent companies such as CJ Cheiljedang Corporation and CJ Corporation. His experience in these organizations has allowed him to develop and refine his innovative techniques in biotechnology.
Collaborations
Myung Suk Oh has collaborated with several professionals in his field, including Ji Sook Park and Jong Sang Chung. These collaborations have contributed to the advancement of his research and the successful development of his patented processes.
Conclusion
Myung Suk Oh's contributions to the purification of interferon beta highlight his innovative spirit and dedication to advancing biotechnology. His patents not only reflect his expertise but also pave the way for future developments in therapeutic applications.